Coronavirus company news summary – Cipla launches Covi-G for Covid-19 rapid antibody detection – JOYSBIO releases rapid Covid-19 antigen test

19 November 2020 (Last Updated November 19th, 2020 09:15)

Cipla has entered into a licensing agreement with Multi G for the distribution of Multi G's Covi-G rapid antibody test kit across Europe and most emerging markets. Covi-G was among the earliest antibody kits to declare CE compliance and has been commercialised in over countries already. With sensitivity and specificity exceeding 92%, it tests for both IgM and IgG antibodies using a single-prick blood test. It gives results within 10 minutes.

SummerBio, a diagnostic company, has partnered with the University of California Los Angeles (UCLA) and the Los Angeles Unified School District (Los Angeles Unified) to launch high-volume testing for the Covid-19 virus. The SummerBio SARS-CoV-2 Test is a nasal swab test conducted by health professionals and produce results within 24 hours.

JOYSBIO Biotechnology has introduced a new rapid Covid-19 antigen test kitwith a nasal swab that can be inserted approximately 2.5 cm into the nostril. This is less invasive than a conventional nasopharyngeal swab, but simple to use like a saliva test. The SARS-COV-2 Antigen Rapid Test Kit is produces results in 15 minutes and is available at all medical stores for home testing and as per local legislation.

Eurofins Viracor, an infectious disease testing laboratory, has announced the launch of combined SARS-CoV-2 Plus Flu A/B and RSV tests. The tests helps in the early detection of multiple pathogens to enable further treatment decisions.